WuXi Biologics (Cayman) I... (WXXWY)

PNK: WXXWY · Real-Time Price · USD

5.78

0.06 (1.05%)

At close: May 01, 2025, 3:59 PM

WuXi Biologics (Cayman) Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	17.03B	15.27B	10.29B	5.61B	3.98B	2.53B	1.62B	989.03M
Cost of Revenue	10.21B	8.54B	5.46B	3.08B	2.32B	1.52B	958.27M	599.92M
Gross Profit	6.83B	6.72B	4.83B	2.53B	1.66B	1.02B	660.56M	389.11M
Operating Income	4.45B	4.35B	3.17B	1.5B	947.97M	522.38M	410.69M	201.54M
Interest Income	219.18M	51.41M	18.84M	38.13M	56.15M	88.77M	26.95M	413K
Pretax Income	4.17B	5.36B	3.99B	1.97B	1.13B	737.72M	303.69M	175.85M
Net Income	3.4B	4.42B	3.39B	1.69B	1.01B	630.59M	252.63M	141.1M
Selling & General & Admin	1.79B	1.69B	1.13B	721.96M	451.09M	326.1M	175.39M	109.93M
Research & Development	792.58M	689.57M	507.83M	308.97M	260.96M	169.29M	74.48M	53.28M
Other Expenses	n/a	17.94M	837K	4.38M	-1.97M	2.68M	2.29M	2.82M
Operating Expenses	2.38B	1.42B	854.61M	605.34M	588.22M	368.81M	329.93M	161.88M
Interest Expense	158.49M	64.38M	39.19M	42.73M	19.61M	n/a	35.69M	24.16M
Selling & Marketing Expenses	294.01M	162.91M	124.65M	94.42M	77.08M	42.43M	27.62M	15.33M
Cost & Expenses	12.58B	9.96B	6.32B	3.68B	2.91B	1.89B	1.29B	761.8M
Income Tax Expense	603.18M	807.87M	484.54M	273.07M	116.3M	107.26M	51.06M	34.75M
Shares Outstanding (Basic)	2.2B	2.19B	2.2B	2.1B	2B	1.97B	1.72B	850.59M
Shares Outstanding (Diluted)	2.17B	2.19B	2.21B	2.1B	2B	1.97B	1.74B	850.59M
EPS (Basic)	1.54	2.12	1.62	0.86	0.54	0.32	0.16	0.17
EPS (Diluted)	1.56	2.02	1.54	0.80	0.50	0.32	0.15	0.17
EBITDA	5.5B	5.07B	3.62B	1.77B	1.14B	663.91M	498.17M	319.08M
EBIT	4.33B	4.35B	3.17B	1.5B	947.97M	522.38M	339.38M	200M
Depreciation & Amortization	1.17B	800.67M	481.78M	303.01M	221.37M	143.77M	87.48M	93.19M